51 related articles for article (PubMed ID: 6911340)
1. [Fibrinopeptide].
Shibusawa K
Kango; 1981 Apr; 33(4):82. PubMed ID: 6911340
[No Abstract] [Full Text] [Related]
2. [Biological properties of fibrinogen degradation products by thrombin].
Buczko W
Pol Tyg Lek; 1981 Jun; 36(23):855-6. PubMed ID: 7024948
[No Abstract] [Full Text] [Related]
3. Effects of extravascular clotting on fibrinopeptide A levels in blood.
Wilner GD; Chatpar P; Te A; Horowitz J
J Lab Clin Med; 1978 Feb; 91(2):205-13. PubMed ID: 621423
[No Abstract] [Full Text] [Related]
4. [Endogenous peptides--physiological regulators of coagulative conversion of fibrinogen].
Byshevskiĭ ASh; Chiriat'ev EA; Leonova OP
Gematol Transfuziol; 1991 Apr; 36(4):28-31. PubMed ID: 2065963
[No Abstract] [Full Text] [Related]
5. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313
[TBL] [Abstract][Full Text] [Related]
6. Studies on the functionality of newly synthesized fibrinogen after treatment of acute myocardial infarction with streptokinase, increase in the rate of fibrinopeptide release.
Reganon E; Vila V; Aznar J; Lacueva V; Martinez V; Ruano M
Thromb Haemost; 1993 Dec; 70(6):978-83. PubMed ID: 8165621
[TBL] [Abstract][Full Text] [Related]
7. [Role of fibrinopeptide A and D-dimer in diagnostics of hemostasis disorders].
Riabov GA; Pasechnik IN; Azizov IuM
Anesteziol Reanimatol; 2003; (1):69-74. PubMed ID: 12696462
[No Abstract] [Full Text] [Related]
8. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
Rooney MM; Mullin JL; Lord ST
Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
[TBL] [Abstract][Full Text] [Related]
9. Human endothelial cells suppress prothrombin activation in nonanticoagulated whole blood in vitro.
Biedermann B; Rosenmund A; Muller M; Kohler HP; Haeberli A; Straub PW
J Lab Clin Med; 1994 Sep; 124(3):339-47. PubMed ID: 8083577
[TBL] [Abstract][Full Text] [Related]
10. The in vitro inhibitory effect on thrombin by 2,3-diphosphoglycerate.
Del Principe D; Strappini PM; Del Vecchio S; Menichelli A; Biancini G; Cosmi EV; Bastianon V; D'Arcangelo C
Thromb Haemost; 1981 Oct; 46(3):581-3. PubMed ID: 7031980
[TBL] [Abstract][Full Text] [Related]
11. Analysis of human fibrinopeptides by high-performance liquid chromatography.
Kehl M; Lottspeich F; Henschen A
Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1661-4. PubMed ID: 7319478
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen survival and fibrinopeptide A in acute leukemia.
Castaman G; Galloni E; Dri AV; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
[TBL] [Abstract][Full Text] [Related]
13. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
14. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease.
Yoda Y; Abe T
Thromb Haemost; 1981 Dec; 46(4):706-9. PubMed ID: 7330820
[TBL] [Abstract][Full Text] [Related]
15. Fibrin polymerization studied by static and dynamic light-scattering as a function of fibrinopeptide A release.
Wiltzius P; Dietler G; Känzig W; Häberli A; Straub PW
Biopolymers; 1982 Nov; 21(11):2205-23. PubMed ID: 7171733
[No Abstract] [Full Text] [Related]
16. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
Weisel JW; Veklich Y; Gorkun O
J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of fibrin molecules containing fibrinopeptide A alters clot ultrastructure and decreases permeability.
Flood VH; Nagaswami C; Chernysh IN; Al-Mondhiry HA; Weisel JW; Farrell DH
Br J Haematol; 2007 Jul; 138(1):117-24. PubMed ID: 17555455
[TBL] [Abstract][Full Text] [Related]
18. Structural examination of the influence of phosphorylation on the binding of fibrinopeptide A to bovine thrombin.
Maurer MC; Peng JL; An SS; Trosset JY; Henschen-Edman A; Scheraga HA
Biochemistry; 1998 Apr; 37(17):5888-902. PubMed ID: 9558322
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive effects of fibrinogen on saphenous vein.
Hicks RC; Golledge J; Mir-Hasseine R; Powell JT
Nature; 1996 Feb; 379(6568):818-20. PubMed ID: 8587603
[TBL] [Abstract][Full Text] [Related]
20. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
